Loading
RI
RxElite, Inc. Stock: price and insider trades · United States
RxElite, Inc.: what insiders have been doing
Insider filings for RxElite, Inc. are scarce in the SEC (Form 4) feed, the latest one published on 21 November 2008. This page will fill in as new trades are disclosed. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
12
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 21 November 2008
Declarations12 total
630,000 shares@ US$0.11Common StockSEC:0001144204-08-066273:0
28,125 shares@ US$0.11Common StockSEC:0001144204-08-066273:1
1,050,000 shares@ US$0.11Common StockSEC:0001407527-08-000003:0
371,206 shares@ US$0.11Common StockSEC:0001407527-08-000003:1
1,000,000 shares0Common StockSEC:0001144204-08-034878:0
100,000 shares0Common StockSEC:0001144204-08-034878:1
1,000,000 shares0Common StockSEC:0001144204-08-034880:0
100,000 shares0Common StockSEC:0001144204-08-034880:1
1,000,000 shares0Common StockSEC:0001144204-08-034876:0
100,000 shares0Common StockSEC:0001144204-08-034876:1
1,000,000 shares0Common StockSEC:0001144204-08-034873:0
100,000 shares0Common StockSEC:0001144204-08-034873:1
12 of 12 declarations
About RxElite, Inc.
RxElite, Inc. is a company listed on the XNAS market, specializing in the development and distribution of pharmaceutical products. It focuses on innovation in the healthcare sector.
